SweetValueLab
Write for us

DexCom, Inc. — Financial Statements & Ratios

DXCM
NASDAQHealthcareMedical - DevicesCIK 0001093557dexcom.comAbout DXCM
Last close · Oct 16, 202686.04−1.67 (−1.90%)
Market cap$32.5B

Key indicators

Revenue5.0BTTM+15.5% on a year earlier+24.0% a year, FY2018–FY2025
Fiscal yearFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025TTMFY2026EFY2027EFY2028E
Growth
1.0B 1.5B+43.1%1.9B+30.5%2.4B+27.1%2.9B+18.8%3.6B+24.5%4.0B+11.3%4.7B+15.6%5.0B+15.5%5.2B 5.8B 6.5B
— 43.1% 30.5% 27.1% 18.8% 24.5% 11.3% 15.6% 15.5% 12.2% 10.8% 11.3%
-$0.36 $0.28+176.4%$1.27+360.0%$0.39−69.4%$0.82+111.6%$1.30+58.5%$1.42+9.2%$2.09+47.2%$2.52+76.2%$2.67 $3.13 $3.73
Profitability
64.4% 63.1%−1.2 pt66.4%+3.3 pt68.6%+2.2 pt64.7%−3.9 pt63.2%−1.5 pt60.5%−2.7 pt60.1%−0.4 pt62.5%+3.7 pt· · ·
-18.1% 9.6%+27.7 pt15.5%+5.9 pt10.9%−4.7 pt13.4%+2.6 pt16.5%+3.1 pt14.9%−1.6 pt19.6%+4.7 pt22.9%+6.9 pt· · ·
-12.3% 6.8%+19.2 pt25.6%+18.8 pt6.3%−19.3 pt11.7%+5.4 pt14.9%+3.2 pt14.3%−0.7 pt17.9%+3.7 pt20.1%+6.8 pt· · ·
-19.2% 11.5%+30.6 pt27.0%+15.6 pt6.9%−20.2 pt16.0%+9.1 pt26.2%+10.2 pt27.4%+1.2 pt30.5%+3.1 pt— · · ·
Cash
56.1M 134.5M+139.8%276.6M+105.7%53.3M−80.7%304.7M+471.7%511.9M+68.0%630.7M+23.2%1.1B+70.8%1.4B+146.1%· · ·
5.4% 9.1%+3.7 pt14.4%+5.2 pt2.2%−12.2 pt10.5%+8.3 pt14.1%+3.7 pt15.6%+1.5 pt23.1%+7.5 pt28.3%+15.0 pt· · ·
Balance sheet
1.52x 1.20x−0.32x0.91x−0.29x0.76x−0.16x0.56x−0.19x1.18x+0.61x0.59x−0.59x0.45x−0.14x0.47x−0.01x· · ·
352.80M 369.20M+4.6%390.00M+5.6%400.40M+2.7%427.50M+6.8%425.50M−0.5%412.70M−3.0%405.50M−1.7%390.10M−4.4%· · ·

E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jun 30, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period. EPS and share counts before a stock split are restated in today's share terms.